14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 3.920 2 days ( -8.11 % )
Last Price $9.60 8.11 %
High/ Low $8.56 - $9.63 23.31%
Chg 7 Days 17.79 % $8.15 $9.60
Chg 30 Days 4.80 % $9.16 $9.60
Chg 12 mos 12.35 % $8.55 $9.60
Trend - 3 mos -18.71 % Width: 56.31 %
Trend - 12 mos 17.40 % Width: 343.64 %
Pred. range - 3 mos $5.43 - $8.49 -43.45 % - -11.61 %
Pred. range - 12 mos $3.42 - $15.19 -64.32 % - 58.27 %
Short MA avg 3 mos Buy Jun 20, 2024 - 4 days
Long MA avg 3 mos Buy Jun 20, 2024 - 4 days
Short/Long MA avg 3 mos Buy Jun 20, 2024 - 4 days
Short MA avg 12 mos Buy Jun 20, 2024 - 4 days
Long MA avg 12 mos Buy Jun 24, 2024 - 2 days
Short/Long MA avg 12 mos Sell Jun 05, 2024 - 14 days
Pivot Short Sell May 22, 2024 - 23 days
Bollinger Buy Mar 25, 2024 - 64 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp ... ARQT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT